Implementing a Clinical-Decision Support Tool to Guide Early Peanut Introduction: Results of 18-Months of Intervention
Friday, April 28, 2023
5:00 PM – 5:15 PM ET
Location: Convention Center: 209 A
Publication Number: 595.6
Lucy Bilaver, Northwestern University The Feinberg School of Medicine, Chicago, IL, United States; Neil Thivalapill, Northwestern University The Feinberg School of Medicine, Chicago, IL, United States; Jialing Jiang, Northwestern University The Feinberg School of Medicine, Chicago, IL, United States; Joy Laurienzo Panza, National Institutes of Health, Rockville, MD, United States; Alkis Togias, NIH, Bethesda, MD, United States; Ruchi Gupta, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
Presenting Author(s)
Ruchi Gupta, MD, MPH
Professor of Pediatrics & Medicine Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
Disclosure(s):
Lucy Bilaver, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Neil Thivalapill, M.S.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jialing Jiang, BA: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Joy Laurienzo Panza, Bachelor of Science in Nursing: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Alkis Togias, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ruchi Gupta, MD, MPH: Aimmune (Ongoing) (Products/Services: Advisory Committee); Allergenis (Ongoing) (Products/Services: Advisory Committee); Food Allergy Research & Education (FARE) (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Genentech (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Melchiorre Family Foundation (Terminated, August 31, 2021) (Products/Services: Research Support including clinical trials & the principal or named investigator); National Institutes of Health (NIH) (R21 ID # AI135705, R01 ID # AI130348, U01 ID # AI138907) (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Novartis (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Sunshine Charitable Foundation (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); The Walder Foundation (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Yobee Care, Inc (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)